Skip to main content
Fig. 10 | Biomarker Research

Fig. 10

From: Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling

Fig. 10

Fer-1 restored the proliferative capacity of combined group cells. A-C The cell viability of MDA-MB-231 cells treated with IN10018, crizotinib, and 1 uM of Fer-1 for 24 h. D-F The cell viability of Hs578T cells treated with IN10018, crizotinib, and 1 uM of Fer-1 for 24 h. G, H EdU staining results of MDA-MB-231 and Hs578T cells. I, J Quantitative analysis of EdU-positive cells. Significant levels: ns = not significant (P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001

Back to article page